• Publications
  • Influence
Guidelines for the diagnosis and treatment of pulmonary hypertension
Guidelines and Expert Consensus Documents summarise and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategiesExpand
  • 1,139
  • 55
  • PDF
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
ESC Committee for Practice Guidelines (CPG): Silvia G. Priori (Chairperson) (Italy), Maria Angeles Alonso Garcia (Spain), Jean-Jacques Blanc (France), Andrzej Budaj (Poland), Martin Cowie (UK),Expand
  • 994
  • 38
Pulmonary hypertension due to left heart diseases.
Pulmonary hypertension (PH), a common complication of left heart diseases (LHD), negatively impacts symptoms, exercise capacity, and outcome. Although the true prevalence of PH-LHD is unknown, aExpand
  • 437
  • 38
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
BACKGROUND Data on the effect of initial combination therapy with ambrisentan and tadalafil on long-term outcomes in patients with pulmonary arterial hypertension are scarce. METHODS In thisExpand
  • 552
  • 32
  • PDF
Pulmonary hypertension in chronic obstructive pulmonary disease
Pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD). Its presence is associated with shorter survival and worse clinical evolution. In COPD, pulmonaryExpand
  • 443
  • 27
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonaryExpand
  • 384
  • 22
  • PDF
Inflammation, growth factors, and pulmonary vascular remodeling.
Inflammatory processes are prominent in various types of human and experimental pulmonary hypertension (PH) and are increasingly recognized as major pathogenic components of pulmonary vascularExpand
  • 563
  • 21
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry
Background— Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel of venous thromboembolism with fatal natural history; however, many cases can be cured by pulmonary endarterectomy.Expand
  • 529
  • 21
  • PDF
[Pulmonary hypertension in chronic lung diseases].
Chronic obstructive lung disease (COPD) and diffuse parenchymal lung diseases (DPLD), including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high incidence of pulmonaryExpand
  • 198
  • 21
  • PDF